FlexCath Cross™ transseptal solution
For transseptal access
FlexCath Cross™ is an integrated transseptal solution with a zero exchange workflow and pairs with commercially available sheaths for both mechanical and radiofrequency (RF) crossing.
Overview
The first and only transseptal access system specifically engineered to pair with commercially available sheaths, including the Medtronic FlexCath Advance™ steerable sheath.
The FlexCath Cross™ system enables a zero exchange transseptal workflow, which adds efficiencies and simplifies left atrial access procedures. FlexCath Cross™ is the only transseptal access system on the market cleared for both mechanical and RF crossing.
Product benefits
Zero exchange workflow
The integrated needle/dilator design removes the need for needle, guidewire, transseptal, and therapeutic sheath exchanges. FlexCath Cross™ helps reduce procedural time of transseptal access by up to 49.9% on average in comparison to traditional mechanical solutions.1,2
Zero sheath exchanges
Dilators compatible with leading industry sheaths eliminate the need for separate transseptal and therapeutic sheaths.
Hear from an experienced Electrophysiologist.
49.9%
average reduction in time for transseptal access1,2
Versatility for your procedures
Choose the FlexCath Cross™ model that fits with your existing sheath preferences for transseptal access. FlexCath Cross™ is compatible with the following industry-leading introducers and with both mechanical and RF crossing.
Product information
Specifications
- Guidewire
- Conforms to any sheath curve
- Integrated needle (advances 4 mm)
- Dilator shaft
- EGM or RF energy connector
- Needle slide button
- Luer fitting guidewire lumen
Competitive comparison
| Feature |
FlexCath Cross™ |
BRK™* |
SafeSept®* |
NRG®* |
VersaCross®* |
|---|---|---|---|---|---|
| Integrated guidewire design reduces exchanges |
◾ |
x |
x |
x |
◾ |
| Indicated for use mechanically or with RF |
◾ |
x |
x |
x |
x |
| Reposition without requiring wire/needle exchange |
◾ |
x |
x |
x |
◾ |
| Engineered to pair with leading sheaths |
◾ |
x |
x |
x |
x |
Request more information
FlexCath Cross™
*
™Third-party brands are trademarks of their respective owners. All other brands are trademarks of a Medtronic company.
References
1
Rizzi S, Pannone L, Monaco C, et al. First experience with a transseptal puncture using a novel transseptal crossing device with integrated dilator and needle. J Interv Card Electrophysiol. December 2022;65(3):731–737.
2
Yong Ji S, et al. Use of the Novel AcQCross Transseptal System Improves Procedural Efficiency Compared to Conventional Transseptal Puncture Technique. Presented at AF Symposium 2022.
